4.8 Article

PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer

期刊

ONCOGENE
卷 35, 期 15, 页码 1943-1954

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2015.259

关键词

-

资金

  1. National Natural Science Foundation of China [90813038, 31371424, 31171360, 31000627, 81201659, 81230077]
  2. Ministry of Education of China [20102104110016, IRT 13101]

向作者/读者索取更多资源

The p21-activated kinase 5 (PAK5) is overexpressed in advanced cancer and the transcription factor E47 is a direct repressor of E-cadherin and inducer of epithelial-mesenchymal transition (EMT). However, the relationship between PAK5 and E47 has not been explored. In this study, we found that PAK5-mediated E47 phosphorylation promoted EMT in advanced colon cancer. PAK5 interacted with E47 and phosphorylated E47 on Ser39 under hepatocyte growth factor (HGF) stimulation, which decreased cell-cell cohesion, increased cell migration and invasion in vitro and promoted metastasis in a xenograft model. Furthermore, phosphorylation of E47 facilitated its accumulating in nucleus in an importin a-dependent manner, and enhanced E47 binding to E-cadherin promoter directly, leading to inhibition of E-cadherin transcription. In contrast, PAK5-knockdown resulted in blockage of HGF-induced E47 phosphorylation, attenuated association of E47 with importin a and decreased E47 binding to E-cadherin promoter. In addition, we demonstrated a close correlation between PAK5 and phospho-Ser39 E47 expression in colon cancer specimens. More importantly, high expression of phospho-E47 was associated with an aggressive phenotype of colon cancer and nuclear phospho-E47 staining was found in certain cases of colon cancer with metastasis. Collectively, E47 is a novel substrate of PAK5, and PAK5-mediated phosphorylation of E47 promotes EMT and metastasis of colon cancer, suggesting that phosphorylated E47 on Ser39 may be a potential therapeutic target in progressive colon cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Genetics & Heredity

Structure, biochemistry, and biology of PAK kinases

Rakesh Kumar, Rahul Sanawar, Xiaodong Li, Feng Li

Article Chemistry, Medicinal

Structure-Based Design of 6-Chloro-4-aminoquinazoline-2-carboxamide Derivatives as Potent and Selective p21-Activated Kinase 4 (PAK4) Inhibitors

Chenzhou Hao, Fan Zhao, Hongyan Song, Jing Guo, Xiaodong Li, Xiaolin Jiang, Ran Huan, Shuai Song, Qiaoling Zhang, Ruifeng Wang, Kai Wang, Yu Pang, Tongchao Liu, Tianqi Lu, Wanxu Huang, Jian Wang, Bin Lin, Zhonggui He, Haitao Li, Feng Li, Dongmei Zhao, Maosheng Cheng

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Cell Biology

PAK4 regulates G6PD activity by p53 degradation involving colon cancer cell growth

Xiumei Zhang, Xia Zhang, Yang Li, Yangguang Shao, Jianying Xiao, Ge Zhu, Feng Li

CELL DEATH & DISEASE (2017)

Article Medicine, Research & Experimental

A Novel Pak1/ATF2/miR-132 Signaling Axis Is Involved in the Hematogenous Metastasis of Gastric Cancer Cells

Funan Liu, Zhenguo Cheng, Xiaodong Li, Yanshu Li, Hongyan Zhang, Jiabin Li, Furong Liu, Huimian Xu, Feng Li

MOLECULAR THERAPY-NUCLEIC ACIDS (2017)

Article Biochemistry & Molecular Biology

HSF1, in association with MORC2, downregulates ArgBP2 via the PRC2 family in gastric cancer cells

Yuxin Tong, Yan Li, Hui Gu, Chunyu Wang, Funan Liu, Yangguang Shao, Feng Li

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)

Article Oncology

Exosomes from BM-MSCs increase the population of CSCs via transfer of miR-142-3p

Hongdan Li, Feng Li

BRITISH JOURNAL OF CANCER (2018)

Article Biochemistry & Molecular Biology

A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERα-positive breast cancer cells

Yanshu Li, Hongyan Zhang, Yue Zhao, Chunyu Wang, Zhenguo Cheng, Lina Tang, Yunling Gao, Furong Liu, Jiabin Li, Yan Li, Yang Li, Nanxi Geng, Xue Rui, Yuee Teng, Yunpeng Liu, Liu Cao, Rakesh Kumar, Feng Jin, Feng Li

ONCOGENE (2019)

Article Oncology

MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of NDRG1

Jiao Liu, Yangguang Shao, Yuxin He, Ke Ning, Xi Cui, Furong Liu, Zhenning Wang, Feng Li

CANCER SCIENCE (2019)

Article Biochemistry & Molecular Biology

A novel PAK4-CEBPB-CLDN4 axis involving in breast cancer cell migration and invasion

Fei Wang, Yunling Gao, Lina Tang, Ke Ning, Nanxi Geng, Hongyan Zhang, Yanshu Li, Yang Li, Furong Liu, Feng Li

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Article Oncology

A PAK5-DNPEP-USP4 axis dictates breast cancer growth and metastasis

Nanxi Geng, Yang Li, Wenyu Zhang, Fei Wang, Xu Wang, Zining Jin, Yao Xing, Danni Li, Hongyan Zhang, Yanshu Li, Xiaodong Li, Maosheng Cheng, Feng Jin, Feng Li

INTERNATIONAL JOURNAL OF CANCER (2020)

Article Oncology

Histone demethylase Jumonji domain-containing 1A inhibits proliferation and progression of gastric cancer by upregulating runt-related transcription factor 3

Ke Ning, Yangguang Shao, Yuxin He, Fei Wang, Xi Cui, Furong Liu, Danni Li, Feng Li

CANCER SCIENCE (2020)

Article Cell Biology

PAK5 promotes RNA helicase DDX5 sumoylation and miRNA-10b processing in a manner in breast cancer

Yang Li, Yao Xing, Xu Wang, Bingtao Hu, Xin Zhao, Hongyan Zhang, Fuyi Han, Nanxi Geng, Fei Wang, Yanshu Li, Jiabin Li, Feng Jin, Feng Li

Summary: This study revealed the important role of PAK5 in breast cancer, with PAK5 deficiency inhibiting breast tumor formation. Phosphorylation of DDX5 is a substrate of PAK5, promoting breast cancer cell proliferation and metastasis. PAK5 facilitates the phosphorylation-dependent sumoylation of DDX5, enhancing microRNA biogenesis.

CELL REPORTS (2021)

Article Biochemistry & Molecular Biology

PAK5-mediated AIF phosphorylation inhibits its nuclear translocation and promotes breast cancer tumorigenesis

Yao Xing, Yang Li, Bingtao Hu, Fuyi Han, Xin Zhao, Hongyan Zhang, Yanshu Li, Danni Li, Jiabin Li, Feng Jin, Feng Li

Summary: The study revealed that PAK5 inhibits apoptosis in breast cancer cells by preventing the nuclear translocation of AIF. PAK5 phosphorylates AIF to inhibit its complex formation with importin β3, leading to decreased nuclear translocation. The expression of PAK5 and AIF in breast cancer is positively correlated with poor patient prognosis, while PAK5 expression is negatively correlated with AIF nuclear translocation.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Article Biochemistry & Molecular Biology

PAK4 phosphorylating RUNX1 promotes ERα-positive breast cancer-induced osteolytic bone destruction

Lina Tang, Yunling Gao, Yongqi Song, Yang Li, Yanshu Li, Hongyan Zhang, Danni Li, Jiabin Li, Caigang Liu, Feng Li

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Article Oncology

LC-0882 targets PAK4 and inhibits PAK4-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells

Hong-Yan Zhang, Jian Zhang, Chen-Zhou Hao, Ying Zhou, Jian Wang, Mao-Sheng Cheng, Dong-Mei Zhao, Feng Li

AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH (2017)

暂无数据